Skip to content

Author

Feng Liu

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

CHAF1A identified as a candidate biomarker and potential therapeutic target in Burkitt lymphoma through integrated bioinformatics and histopathological analysis.

CHAF1A is identified as a candidate biomarker associated with BL that, in exploratory single-dataset analysis, also correlates with immune-cell infiltration and is nominated as a potential therapeutic target that warrants functional validation in future studies.

Wenyuan Lin, Bei-Li Chen, Zhi-Mei Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.